Bupropion monotherapy alters neurotrophic and inflammatory markers in patients of major depressive disorder
Publication date: Available online 11 November 2020Source: Pharmacology Biochemistry and BehaviorAuthor(s): Sana Tafseer, Rachna Gupta, Rafat Ahmad, Seema Jain, M.S. Bhatia, Lalit K. Gupta
Source: Pharmacology Biochemistry and Behavior - Category: Biochemistry Source Type: research
More News: Biochemistry | Brain | Bupropion | Depression | Drugs & Pharmacology | Neurology | Wellbutrin